MX369395B - Modulacion del crecimiento celular y glucosilacion en la produccion de glucoproteina recombinante. - Google Patents

Modulacion del crecimiento celular y glucosilacion en la produccion de glucoproteina recombinante.

Info

Publication number
MX369395B
MX369395B MX2016010236A MX2016010236A MX369395B MX 369395 B MX369395 B MX 369395B MX 2016010236 A MX2016010236 A MX 2016010236A MX 2016010236 A MX2016010236 A MX 2016010236A MX 369395 B MX369395 B MX 369395B
Authority
MX
Mexico
Prior art keywords
glycosylation
cell growth
medium
modulation
conditions
Prior art date
Application number
MX2016010236A
Other languages
English (en)
Spanish (es)
Other versions
MX2016010236A (es
Inventor
Popp Oliver
Beaucamp Nicola
DRABNER Georg
Esslinger Stephanie
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50184787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX369395(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2016010236A publication Critical patent/MX2016010236A/es
Publication of MX369395B publication Critical patent/MX369395B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2016010236A 2014-02-27 2015-02-24 Modulacion del crecimiento celular y glucosilacion en la produccion de glucoproteina recombinante. MX369395B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14157030 2014-02-27
PCT/EP2015/053804 WO2015128314A1 (en) 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production

Publications (2)

Publication Number Publication Date
MX2016010236A MX2016010236A (es) 2016-10-13
MX369395B true MX369395B (es) 2019-11-07

Family

ID=50184787

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010236A MX369395B (es) 2014-02-27 2015-02-24 Modulacion del crecimiento celular y glucosilacion en la produccion de glucoproteina recombinante.

Country Status (20)

Country Link
US (3) US20170058309A1 (cg-RX-API-DMAC7.html)
EP (1) EP3110961B1 (cg-RX-API-DMAC7.html)
JP (2) JP6831702B2 (cg-RX-API-DMAC7.html)
KR (1) KR102280638B1 (cg-RX-API-DMAC7.html)
CN (1) CN106133146B (cg-RX-API-DMAC7.html)
BR (1) BR112016017660B1 (cg-RX-API-DMAC7.html)
CA (1) CA2937611C (cg-RX-API-DMAC7.html)
DK (1) DK3110961T3 (cg-RX-API-DMAC7.html)
ES (1) ES2769003T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20200100T1 (cg-RX-API-DMAC7.html)
HU (1) HUE047575T2 (cg-RX-API-DMAC7.html)
LT (1) LT3110961T (cg-RX-API-DMAC7.html)
MX (1) MX369395B (cg-RX-API-DMAC7.html)
PL (1) PL3110961T3 (cg-RX-API-DMAC7.html)
PT (1) PT3110961T (cg-RX-API-DMAC7.html)
RS (1) RS59881B1 (cg-RX-API-DMAC7.html)
RU (1) RU2712562C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201606856SA (cg-RX-API-DMAC7.html)
SI (1) SI3110961T1 (cg-RX-API-DMAC7.html)
WO (1) WO2015128314A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3783093B1 (en) 2011-11-21 2025-04-16 Innovation Hammer LLC Method for photosafening by utilization of exogenous glycopyranosides
RS59881B1 (sr) * 2014-02-27 2020-03-31 Hoffmann La Roche Modulacija ćelijskog rasta i glikozilacije u rekombinantnoj proizvodnji glikoproteina
CA2969225C (en) 2014-12-01 2023-08-22 Amgen Inc. Process for manipulating the level of glycan content of a glycoprotein
AU2017255439B2 (en) 2016-04-29 2019-11-14 Innovation Hammer Llc Formulations and methods for treating photosynthetic organisms and enhancing qualities and quantities of yields with glycan composite formulations
AU2018235928B2 (en) 2017-03-14 2023-09-21 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
WO2019077628A1 (en) * 2017-10-16 2019-04-25 Council Of Scientific & Industrial Research ZINC SUPPLEMENTATION TO DECREASE GALACTOSYLATION OF RECOMBINANT GLYCOPROTEINS
MA52007A (fr) * 2018-03-16 2021-01-20 Genzyme Corp Procédés d'amélioration de la viabilité cellulaire dans un bioréacteur de production
US12325737B2 (en) * 2018-03-26 2025-06-10 Amgen Inc. Total afucosylated glycoforms of antibodies produced in cell culture
US20210147532A1 (en) * 2018-05-24 2021-05-20 Ares Trading S.A. Method for controlling the afucosylation level of a glycoprotein composition
HU231514B1 (hu) 2018-11-07 2024-07-28 Richter Gedeon Nyrt. Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer
CN113015805B (zh) * 2018-11-13 2024-12-03 詹森生物科技公司 抗cd38抗体产生期间的痕量金属的控制
JP2020188737A (ja) * 2019-05-23 2020-11-26 東ソー株式会社 抗体依存性細胞傷害活性が向上した抗体の製造方法
MX2022013173A (es) * 2020-04-24 2022-11-30 Hoffmann La Roche Modulacion de enzimas y vias con compuestos de sulfhidrilo y sus derivados.
IL309996A (en) * 2021-07-09 2024-03-01 Janssen Biotech Inc Production methods for the production of anti-TNF antibody compositions
US20230038355A1 (en) * 2021-07-09 2023-02-09 Janssen Biotech, Inc. Manufacturing Methods for Producing Anti-IL12/IL23 Antibody Compositions
EP4762088A1 (en) * 2023-08-16 2026-06-24 Glaxosmithkline Intellectual Property Limited Method of controlling antibody glycosylation profile

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
EP2221361A3 (en) 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
DE69929198T2 (de) * 1998-05-29 2006-08-10 Genentech, Inc., South San Francisco Zellkulturverfahren für die produktion von glycoproteinen
JP2001120262A (ja) * 1999-10-26 2001-05-08 Welfide Corp 生理活性物質の産生増強方法
DE60230858D1 (de) 2001-02-15 2009-03-05 Centocor Inc Chemisch definiertes medium für kultivierte säugerzellen
US20050287666A1 (en) * 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
ES2361559T3 (es) 2004-11-02 2011-06-20 Ares Trading S.A. Medio de cultivo de células exento de suero para mamíferos.
US20070231895A1 (en) 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
EP3026109B1 (en) 2005-12-08 2022-03-09 Amgen Inc. Improved production of glycoproteins using manganese
DK2041270T3 (da) * 2006-07-13 2014-01-27 Wyeth Llc Fremstilling af glycoproteiner
MX2009004519A (es) 2006-11-03 2009-05-12 Wyeth Corp Sustancias que inhiben la glucolisis en un cultivo de celulas.
CA2679941C (en) 2007-03-02 2016-09-20 Wyeth Use of copper and glutamate in cell culture for production of polypeptides
US20110053223A1 (en) 2009-08-14 2011-03-03 Robert Bayer Cell culture methods to make antibodies with enhanced adcc function
WO2011095596A1 (en) * 2010-02-04 2011-08-11 Vivalis Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
LT2563906T (lt) 2010-04-26 2018-02-26 Novartis Ag Cho ląstelių kultivavimo būdas
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
RU2592680C2 (ru) 2011-04-29 2016-07-27 Биокон Рисерч Лимитед Способ снижения накопления лактата при культивировании и способ получения антитела
EP2809773B1 (en) 2012-01-30 2020-09-02 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of glycoprotein composition
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
RS59881B1 (sr) * 2014-02-27 2020-03-31 Hoffmann La Roche Modulacija ćelijskog rasta i glikozilacije u rekombinantnoj proizvodnji glikoproteina

Also Published As

Publication number Publication date
CA2937611C (en) 2023-01-03
PT3110961T (pt) 2020-01-29
ES2769003T3 (es) 2020-06-24
EP3110961B1 (en) 2019-11-27
RS59881B1 (sr) 2020-03-31
HUE047575T2 (hu) 2020-04-28
US20210222220A1 (en) 2021-07-22
JP2020054351A (ja) 2020-04-09
WO2015128314A1 (en) 2015-09-03
HRP20200100T1 (hr) 2020-04-03
EP3110961A1 (en) 2017-01-04
JP6934507B2 (ja) 2021-09-15
US20240327890A1 (en) 2024-10-03
SI3110961T1 (sl) 2020-03-31
RU2016138176A (ru) 2018-03-29
RU2712562C2 (ru) 2020-01-29
KR102280638B1 (ko) 2021-07-22
US20170058309A1 (en) 2017-03-02
CN106133146B (zh) 2021-05-04
RU2016138176A3 (cg-RX-API-DMAC7.html) 2018-10-29
CN106133146A (zh) 2016-11-16
PL3110961T3 (pl) 2020-04-30
JP6831702B2 (ja) 2021-02-17
MX2016010236A (es) 2016-10-13
DK3110961T3 (da) 2020-02-03
KR20160125514A (ko) 2016-10-31
CA2937611A1 (en) 2015-09-03
BR112016017660B1 (pt) 2022-04-19
LT3110961T (lt) 2020-02-10
JP2017506515A (ja) 2017-03-09
SG11201606856SA (en) 2016-09-29
BR112016017660A2 (cg-RX-API-DMAC7.html) 2017-08-08

Similar Documents

Publication Publication Date Title
MX2016010236A (es) Modulacion del crecimiento celular y glucosilacion en la produccion de glucoproteina recombinante.
EP4446338A3 (en) Cells and method of cell culture
MX2025008210A (es) Microbioreactor de flujo continuo
MY207701A (en) Methods of producing omega-hydroxylated fatty acid derivatives
MY156588A (en) Systems using cell culture for production of isoprene
EP4148121A3 (en) Cell-controlled perfusion in continuous culture
WO2019014310A8 (en) Biological methods for preparing terpenes
NZ703137A (en) Cells for producing recombinant iduronate-2-sulfatase
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
MX2010003620A (es) Linea de celulas cho-k1.
SG10201810830UA (en) Cell culture compositions and methods for polypeptide production
WO2011134919A3 (en) Cho cells cultivation process 0
MY159487A (en) Reduced by-product accumulation for improved production of isobutanol
MX345399B (es) Metodo de cultivo de celulas animales.
MX2020013565A (es) Produccion microbiana de dioles grasos.
MX2018004580A (es) Metodo para producir proteina de fusion con dominio fc de igg.
MY182946A (en) Production of organic acids by fermentation at low ph
MY199613A (en) Cell population for transplantation and method for producing same
WO2015004403A3 (fr) Procede de culture cellulaire decouple
MX339769B (es) Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos.
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
MX2016007054A (es) Produccion microbiana de aminas grasas.
WO2017049240A8 (en) Selection of pluripotent cells for production of fertile xy female mice
MX2016002651A (es) Microorganismo modificado para la produccion mejorada de alanina.
MY193587A (en) Genetically modified microorganism for improved production of fine chemicals on sucrose

Legal Events

Date Code Title Description
FG Grant or registration